Verition Fund Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-22,766
| Closed | -$3.95M | – | 2594 |
|
|
2025
Q4 | $3.95M | Sell |
22,766
-42,677
| -65% | -$7.77M | 0.02% | 1055 |
|
|
2025
Q3 | $12.5M | Buy |
65,443
+17,691
| +37% | +$3.14M | 0.05% | 400 |
|
|
2025
Q2 | $8.58M | Buy |
47,752
+13,858
| +41% | +$2.41M | 0.04% | 624 |
|
|
2025
Q1 | $5.73M | Buy |
33,894
+10,280
| +44% | +$1.69M | 0.03% | 745 |
|
|
2024
Q4 | $3.56M | Buy |
23,614
+4,187
| +22% | +$651K | 0.01% | 1144 |
|
|
2024
Q3 | $3.02M | Sell |
19,427
-370
| -2% | -$55.3K | 0.02% | 1170 |
|
|
2024
Q2 | $2.71M | Sell |
19,797
-238
| -1% | -$32.6K | 0.01% | 1094 |
|
|
2024
Q1 | $2.67M | Sell |
20,035
-44
| -0.2% | -$5.71K | 0.02% | 1052 |
|
|
2023
Q4 | $2.77M | Sell |
20,079
-8,127
| -29% | -$1.07M | 0.02% | 682 |
|
|
2023
Q3 | $3.44M | Buy |
28,206
+8,779
| +45% | +$1.17M | 0.04% | 572 |
|
|
2023
Q2 | $2.73M | Sell |
19,427
-3,060
| -14% | -$422K | 0.04% | 548 |
|
|
2023
Q1 | $3.18M | Buy |
+22,487
| New | +$3.22M | 0.04% | 522 |
|
|
2022
Q4 | – | Sell |
-12,613
| Closed | -$1.55M | – | 2279 |
|
|
2022
Q3 | $1.55M | Sell |
12,613
-542
| -4% | -$71.4K | 0.02% | 1087 |
|
|
2022
Q2 | $1.75M | Buy |
13,155
+10,020
| +320% | +$1.37M | 0.03% | 741 |
|
|
2022
Q1 | $429K | Buy |
+3,135
| New | +$437K | 0.01% | 1978 |
|
|
2021
Q3 | – | Sell |
-1,933
| Closed | -$255K | – | 1989 |
|
|
2021
Q2 | $255K | Sell |
1,933
-1,550
| -45% | -$203K | ﹤0.01% | 1433 |
|
|
2021
Q1 | $447K | Buy |
3,483
+314
| +10% | +$38.7K | 0.01% | 916 |
|
|
2020
Q4 | $378K | Sell |
3,169
-4,471
| -59% | -$545K | ﹤0.01% | 749 |
|
|
2020
Q3 | $875K | Buy |
+7,640
| New | +$903K | 0.02% | 405 |
|
|
2018
Q4 | – | Sell |
-49,516
| Closed | -$5.34M | – | 904 |
|
|
2018
Q3 | $5.34M | Buy |
49,516
+40,387
| +442% | +$4.43M | 0.19% | 86 |
|
|
2018
Q2 | $1M | Sell |
9,129
-27,203
| -75% | -$2.83M | 0.06% | 400 |
|
|
2018
Q1 | $3.64M | Buy |
36,332
+16,264
| +81% | +$1.67M | 0.27% | 62 |
|
|
2017
Q4 | $1.98M | Buy |
20,068
+5,346
| +36% | +$507K | 0.18% | 106 |
|
|
2017
Q3 | $1.38M | Buy |
14,722
+8,799
| +149% | +$934K | 0.11% | 192 |
|
|
2017
Q2 | $658K | Buy |
+5,923
| New | +$626K | 0.06% | 321 |
|
|
2017
Q1 | – | Sell |
-2,680
| Closed | -$246K | – | 1221 |
|
|
2016
Q4 | $246K | Buy |
+2,680
| New | +$231K | 0.02% | 935 |
|
|
2015
Q4 | – | Sell |
-8,676
| Closed | -$533K | – | 477 |
|
|
2015
Q3 | $533K | Buy |
+8,676
| New | +$606K | 0.14% | 189 |
|
|
2014
Q4 | – | Sell |
-5,173
| Closed | -$314K | – | 421 |
|
|
2014
Q3 | $314K | Sell |
5,173
-141
| -3% | -$8.69K | 0.04% | 379 |
|
|
2014
Q2 | $312K | Buy |
+5,314
| New | +$311K | 0.03% | 402 |
|
|
2014
Q1 | – | Sell |
-21,770
| Closed | -$1.17M | – | 519 |
|
|
2013
Q4 | $1.17M | Buy |
+21,770
| New | +$1.29M | 0.21% | 82 |
|
Other funds holding DGX
EIG
Verition Fund Management's DGX Position: Q1 2026 in Review
Verition Fund Management sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 22,766 shares — an estimated $3.95M sold.
Verition Fund Management first reported a position in DGX in Q4 2013 and held it in 30 quarters. The position peaked at $12.5M in Q3 2025. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Verition Fund Management reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
- Verition Fund Management sold 22,766 Quest Diagnostics shares in Q1 2026, an estimated $3.95M.
- Verition Fund Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 30 quarters.
- Verition Fund Management's Quest Diagnostics position peaked at $12.5M in Q3 2025.
- 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.